Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity and chronic weight management. The ...
TipRanks on MSN
Lexicon announces publication of preclinical data on ACSL5
Lexicon Pharmaceuticals (LXRX) announced the publication of preclinical data validating Acyl-CoA Synthetase 5 as a target for obesity and chronic ...
Kony Inc. and Exicon Ltd. today announced a partnership to provide a simplified "plug-and-play" solution for enterprise mobile development efforts, where customer engagement counts more than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results